Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancer

Methylation is a primary epigenetic mechanism regulating gene expression. 5-aza-2′-deoxycytidine is an FDA-approved drug prescribed for treatment of cancer by inhibiting DNA-Methyl-Transferase 1 (DNMT1). Results of this study suggest that prolonged treatment with 5-aza-2′-deoxycytidine could induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong Hyun, Kim, Hye-Min, Huong, Pham Thi Thu, Han, Ho-Jin, Hwang, Joonsung, Cha-Molstad, Hyunjoo, Lee, Kyung Ho, Ryoo, In-Ja, Kim, Kyoon Eon, Huh, Yang Hoon, Ahn, Jong Seog, Kwon, Yong Tae, Soung, Nak-Kyun, Kim, Bo Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549914/
https://www.ncbi.nlm.nih.gov/pubmed/31068247
http://dx.doi.org/10.5483/BMBRep.2019.52.5.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549914/
https://www.ncbi.nlm.nih.gov/pubmed/31068247
http://dx.doi.org/10.5483/BMBRep.2019.52.5.055

Ejemplares similares